Previous 10 | Next 10 |
home / stock / pclof / pclof news
Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCi...
2023-05-01 07:59:17 ET PharmaCielo press release ( OTCPK:PCLOF ): Q4 GAAP EPS of -C$0.02. Revenue of C$1.52M (+347.1% Y/Y). PharmaCielo had cash equivalents of $0.2 million at December 31, 2022, the Company reduced its Adjusted EBITDA loss from $16.4 million For ...
During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023. The Company's measured investments in revenue-generating sales channels resulted in revenues of $5.3 million in 2022, almost three-times more than the $1.9 million reported in 2021. Co...
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients in Europe the highest quality high-THC flower product ...
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company - Represents Third Customer in the Country Canada NewsWire PharmaCielo has received a purchase order for CBD Isolate as an API, which will be used by a large pharmaceutical company in Brazil ...
PharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant Terms Canada NewsWire Steady progress against the efficiency plans initiated in mid-2021 with the transition to the current senior management team. Exp...
PharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian Market Canada NewsWire Ease Labs Pharma, a global pharmaceutical company headquartered in Brazil , has received regulato...
PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco Canada NewsWire Represents PharmaCielo's first shipment to Africa . Morocco is pioneering the commercialization of cannabinoid products on the African continent and w...
PharmaCielo Announces TSX Venture Exchange Approval of Warrant Extension Canada NewsWire TORONTO and RIONEGRO, Colombia , Nov. 22, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of ...
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) saw revenues drop sequentially, as the company tries to shave down spending and expand its footprint abroad. The Canadian parent of a Colombia producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia...
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colomb...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colomb...
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and produce...